Clinical Drug Experience Knowledgebase

Acute Disease (Phase 1)

Anemia, Refractory, with Excess of Blasts (Phase 1)

Blast Crisis (Phase 1)

Graft vs Host Disease (Phase 2)

Hodgkin Disease (Phase 2)

Leukemia (Phase 3)

Leukemia, Biphenotypic, Acute (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Leukemia, Mast-Cell (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 1)

Leukemia, Myeloid (Phase 3)

Leukemia, Myeloid, Acute (Phase 3)

Leukemia, Myelomonocytic, Acute (Phase 1)

Leukemia, Myelomonocytic, Chronic (Phase 3)

Leukemia, Myelomonocytic, Juvenile (Phase 3)

Leukemia, Prolymphocytic (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Large B-Cell, Diffuse (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Lymphoma, T-Cell (Phase 1)

Lymphoma, T-Cell, Cutaneous (Phase 1)

Monoclonal Gammopathy of Undetermined Significance (Phase 1)

Multiple Myeloma (Phase 2)

Myelodysplastic-Myeloproliferative Diseases (Phase 1)

Myelodysplastic Syndromes (Phase 3)

Myeloproliferative Disorders (Phase 1)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Paraproteinemias (Phase 1)

Polycythemia (Phase 1)

Polycythemia Vera (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 3)

Primary Myelofibrosis (Phase 1)

Syndrome (Phase 3)

Thrombocythemia, Essential (Phase 1)

Thrombocytosis (Phase 1)

Vitamin D Deficiency (Phase 2)

Waldenstrom Macroglobulinemia (Phase 1)